Navigation Links
UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy
Date:11/29/2007

eizures. There are many different seizure types and epileptic syndromes and effective classification guides treatment and prognosis. Between 70-80% of individuals are successfully treated with one of the more than 20 antiepileptic drugs now available. However, 20-30% of patients have either intractable or uncontrolled seizures or significant adverse side effects secondary to medication highlighting the ongoing need for the development of new antiepileptic drugs.

About Lacosamide: Lacosamide has a novel and dual mode of action. It selectively enhances slow inactivation of sodium channels and interacts with the neuroplasticity-relevant target-collapsin-response mediator protein-2 (CRMP-2).

About UCB

UCB, Brussels, Belgium (http://www.ucb-group.com) is a global leader in the biopharmaceutical industry dedicated to the research, development and commercialisation of innovative pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders and oncology. UCB focuses on securing a leading position in severe disease categories. Employing more than 10,000 people in over 40 countries, UCB achieved revenue of 3.5 billion euro in 2006 on a pro forma basis. UCB S.A. is listed on the Euronext Brussels Exchange and, through its affiliate, owns approx. 89% of the shares of SCHWARZ PHARMA AG. SCHWARZ PHARMA (Monheim, Germany) is a member of the UCB Group.

Forward looking statement

This press release contains forward-looking statements based on current plans, estimates and beliefs of management. Such statements are subject to risks and uncertainties that may cause actual results to be materially different from those that may be implied by such forward-looking statements contained in this press release. Important factors that could result in such differences include: changes in general economic, business an
'/>"/>

SOURCE UCB, Inc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...ls boost cardiovascular disease risk for some,... If you,re worried about reducing your risk of hea...uld quit smoking, eat a healthful diet, exercise r...ake sure your cholesterol levels aren,t too high. ...vels are? , Well, if you don,t have a family h...
(Date:10/10/2008)...RNewswire/ -- Do you think that the blind,can,t us...tend the October,17 open house at the Virginia Reh...ed, and see how instructors there empower the blin...ling lives through non-visual,techniques taught at...venue, is holding an open house to,celebrate the g...
(Date:10/10/2008)...ics range from bullying to incorporating PDAs in m...October 10, 2008 -- Several pediatric experts from...enting at the 2008 American Academy of Pediatrics ...m October 11 - 14 in Boston. Presenters and topics...D, MPH, will present "Promoting Smoke-Free Ho...
(Date:10/10/2008)...RNewswire-USNewswire/ -- Public interest,advocates...ned to make,decisions on the threats posed by merc...er 2008, the 2nd UNEP(2) Open Ended Working Group ...ld form part of a global framework,on mercury, in ... February,2009, where it will be decided whether a...
Breaking Medicine News(10 mins):Health News:Little-Known Fat Can Be a Heartbreaker 2Health News:Little-Known Fat Can Be a Heartbreaker 3Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:Children's National Experts Presenting at American Academy of Pediatrics Conference 2Health News:Elements for a UN Global Framework on Mercury Agreed to 2
...udy analyzing the economic implications of the Cli...veness (CATIE) concludes that the older (first gen...as less expensive and no less effective than the n...trial during initial treatment, suggesting that ol...
...uctive medicine specialist at the University at Bu...e fertility of tobacco smokers// who have low sper...erm from male smokers were washed with a synthetic...tion, there was a doubling in the fertilizing capa...
...d has heard of the illustrious mathematician and p... etched in the ‘Theory of Relativity’. But did you...ability// and could not speak till he turned three...s in school. And, if he could go on to become a wo...
... intensive care doctors are responsible for large ...cally ill patients in the intensive care unit (ICU...length of stay or possible mortality. This resear...mber 2006 of the American Journal of Respiratory a...
Other Medicine News:Health News:Older Medication May Be More Cost-Effective for Some Schizophrenia Patients 2Health News:New Compound May Improve Fertility in Smokers 2Health News:New Compound May Improve Fertility in Smokers 3Health News:Equal Opportunity for the Disabled 2Health News:Large Variations in Cost Has No Effect on Length of Stay or Mortality 2Health News:Large Variations in Cost Has No Effect on Length of Stay or Mortality 3
(Date:10/10/2008)... Data Show Prophylaxis Treatment with Kogenate FS ...ds in Children with No Pre-Existing,Joint Damage, ...ealthCare LLC,announced today that the U.S. Food a...prophylaxis with Kogenate(R) FS Antihemophilic Fac...ing episodes and the risk of,joint damage in patie...
(Date:10/9/2008)...merican Campaign to Spread Awareness and Bring Hop...t. 9 /PRNewswire-USNewswire/ -- 133 million childr...to causes such as natural,disaster, civil war, and...,observing World Orphan Week by calling attention ...ultimedia News Release, go to:, http://www.prnew...
(Date:10/9/2008)... Translational Science Institute, Navigenics, Affy... study, SAN DIEGO, Oct. 9 /- A conso...ers have joined forces in a first-of-its-kind,rese...onal genetic testing,on people who choose to recei...k for developing certain diseases., Sponsored by ...
(Date:10/8/2008)...ngs May Someday Inform Treatments for Spinal Cord,...Newswire-USNewswire/ -- A protein that enables,ner...y role in controlling,the developing nervous syste...nnections to form among nerve cells may provide a ...fer injuries to their nervous system,including sp...
Breaking Medicine Technology:FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Why fish oil is good for you 8785 1Why fish oil is good for you 8785 2Why fish oil is good for you 8785 3Cognitive genetic clues identified in imaging study of alcohol addiction 1723 1Cognitive genetic clues identified in imaging study of alcohol addiction 1723 2Cognitive genetic clues identified in imaging study of alcohol addiction 1723 3Cognitive genetic clues identified in imaging study of alcohol addiction 1723 4Other highlights in the Dec 25 JNCI 8781 1Other highlights in the Dec 25 JNCI 8781 2Other highlights in the Dec 25 JNCI 8781 3Other highlights in the Dec 25 JNCI 8781 4Breast cancer gene mutation more common in Hispanic young black women Stanford NCCC study finds 8778 1Breast cancer gene mutation more common in Hispanic young black women Stanford NCCC study finds 8778 2Breast cancer gene mutation more common in Hispanic young black women Stanford NCCC study finds 8778 3
...HAYWARD, Calif., April 10, 2007 /PRNewswire-FirstC...ata will be presented on the,Company,s clinical an...tor, epothilone and nuclear export inhibitor progr...sociation for Cancer Research,(AACR), being held i...ations on Kosan,s programs are as follows. The,loc...
...nfinity and MedImmune to Present Preclinical Data ... CAMBRIDGE, Mass. and GAITHERSBURG, Md., April 10,..., Inc. (Nasdaq:INFI) and,MedImmune, Inc. (Nasdaq:M...study with an oral formulation of IPI-504 in non-s... the upcoming Annual,Meeting of the American Assoc...
Other Medicine Technology:Kosan Announces Data Presentations at Upcoming AACR Annual Meeting 2Kosan Announces Data Presentations at Upcoming AACR Annual Meeting 3Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 2Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 3Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 4
10 L, Racked, Filtered, Pre-sterilized, 96 tips/rack Recommended for 2, 5 and 10 L pipettes.
Finntip Filters are ideal for PCR and other amplification methods, or for any work where aerosol contamination might occur. They are designed for pipetting DNA/RNA solutions, infectious materials, la
Avant E-Z Rack Premium Low Binding 10 l Microreach Pipet Tips are accurate, contamination free, and allow quantitative transfer of your samples without relying on silicone.
With its wide orifice tip, the Finntip Wide is designed especially for pipetting fragile cell suspensions and macromolecules like genomic DNA. This tip eliminates the mechanical shearing that causes
Medicine Products: